📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: AtriCure

1.1 - Company Overview

AtriCure Logo

AtriCure

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cardiac surgery technologies: systems for surgical ablation of persistent and long-standing persistent atrial fibrillation (Isolator Synergy, EPi-Sense), cryoablation for AF during cardiac surgery (cryoICE), left atrial appendage exclusion devices to reduce stroke risk (AtriClip, AtriClip PRO), and a probe for temporary peripheral nerve ablation to block pain in cardiac and thoracic procedures (cryoICE cryoSPHERE).

Products and services

  • EPi-Sense Guided Coagulation System: Engineers an RF-based guided coagulation system combining epicardial and endocardial ablation, approved to treat long-standing persistent atrial fibrillation using a combined epicardial-endocardial approach
  • Isolator Synergy Ablation System: Builds a surgical-grade ablation system designed for the surgical treatment of persistent and long-standing persistent atrial fibrillation in patients requiring operative management
  • AtriClip LAA Exclusion System: Delivers a medical-grade device used for left atrial appendage exclusion, aiming to reduce stroke risk in patients through targeted exclusion of the appendage.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to AtriCure

Okami Medical Logo

Okami Medical

HQ: United States Website
  • Description: Provider of devices for heart disease treatment, including the LOBO Vascular Occlusion System—a low-profile braided occluder enabling rapid, reliable peripheral artery vessel occlusion. Offerings include LOBO-3 (cleared for peripheral artery occlusion) and LOBO-5, LOBO-7, and LOBO-9 (FDA 510(k) cleared) for peripheral embolization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Okami Medical company profile →
Silver Creek Pharmaceuticals Logo

Silver Creek Pharmaceuticals

HQ: United States Website
  • Description: Provider of protein therapeutics for cardiovascular disease and tissue repair, leveraging Smart Growth Factor technology to create growth factor fusion proteins for damaged tissues. Pipeline includes scp776, a targeted fusion protein in Phase II for acute ischemic stroke with preclinical efficacy in stroke, heart attack, and kidney injury, evaluated in the ARPEGGIO Phase II study for safety and neuroprotection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Silver Creek Pharmaceuticals company profile →
Hemosphere Logo

Hemosphere

HQ: United States Website
  • Description: Provider of proprietary graft-based vascular access solutions for dialysis, marketing the HeRO (Hemodialysis Reliable Outflow) Graft, a fully subcutaneous arteriovenous access solution for end-stage renal disease hemodialysis patients with limited access options and central venous obstruction, designed to maintain long-term access without venous anastomosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hemosphere company profile →
Evalve Logo

Evalve

HQ: United States Website
  • Description: Provider of devices enabling repair of cardiac valves, including a non-surgical mitral valve repair system comprising a steerable guide catheter, a clip delivery system, and an implant device used by interventional cardiologists to reduce mitral regurgitation; engaged in the design, development, manufacture, and marketing of these devices.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Evalve company profile →
NuVera Medical Logo

NuVera Medical

HQ: United States Website
  • Description: Provider of a novel imaging platform for complex cardiovascular procedures and cardiac electrophysiology devices, including QDOT MICRO catheters for mapping and treatment of Type I atrial flutter and drug-refractory recurrent symptomatic paroxysmal atrial fibrillation; the THERMOCOOL SMARTTOUCH SF catheter (used with the CARTO 3 System) for paroxysmal and persistent AF; and the VISITAG SURPOINT module to guide RF energy during ablation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NuVera Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for AtriCure

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to AtriCure

2.2 - Growth funds investing in similar companies to AtriCure

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for AtriCure

4.2 - Public trading comparable groups for AtriCure

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to AtriCure

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About AtriCure

What does AtriCure do?

AtriCure is a provider of cardiac surgery technologies: systems for surgical ablation of persistent and long-standing persistent atrial fibrillation (Isolator Synergy, EPi-Sense), cryoablation for AF during cardiac surgery (cryoICE), left atrial appendage exclusion devices to reduce stroke risk (AtriClip, AtriClip PRO), and a probe for temporary peripheral nerve ablation to block pain in cardiac and thoracic procedures (cryoICE cryoSPHERE).

Who are AtriCure's competitors?

AtriCure's competitors and similar companies include Okami Medical, Silver Creek Pharmaceuticals, Hemosphere, Evalve, and NuVera Medical.

Where is AtriCure headquartered?

AtriCure is headquartered in United States.

How many employees does AtriCure have?

AtriCure has 1,000 employees 🔒.

When was AtriCure founded?

AtriCure was founded in 2010 🔒.

What sector and industry vertical is AtriCure in?

AtriCure is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for AtriCure

Who are the top strategic acquirers in AtriCure's sector and industry

Top strategic M&A buyers and acquirers in AtriCure's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for AtriCure?

Top strategic M&A buyers groups and sectors for AtriCure include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in AtriCure's sector and industry vertical

Which are the top PE firms investing in AtriCure's sector and industry vertical?

Top PE firms investing in AtriCure's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in AtriCure's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in AtriCure's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in AtriCure's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to AtriCure include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in AtriCure's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for AtriCure?

The key public trading comparables and valuation benchmarks for AtriCure include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for AtriCure for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for AtriCure with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in AtriCure's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for AtriCure with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in AtriCure's' sector and industry vertical?

Access recent funding rounds and capital raises in AtriCure's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for AtriCure